Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab.
2020
Cutaneous T-cell lymphoma (CTCL) represents a diagnostic challenge because of its large symptomatic overlap with other common skin conditions such as atopic dermatitis (AD) and psoriasis. Dupilumab has offered promising results in AD treatment; however, concerns exist that its use may exacerbate undiagnosed CTCL. We present a patient with CTCL and concomitant AD who experienced improvement in both CTCL blood involvement and AD following the addition of dupilumab therapy.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
3
References
4
Citations
NaN
KQI